STEVE ASELAGE - 29 Nov 2022 Form 4 Insider Report for Acer Therapeutics Inc.

Role
Director
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Nov 2022
Net transactions value
+$500,000
Form type
4
Filing time
01 Dec 2022, 15:01:54 UTC
Previous filing
09 Jun 2022
Next filing
16 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACER Common Stock Purchase $500,000 +409,836 +555% $1.22 483,741 29 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.